- Reduces the risk of heart attacks and strokes in patients with acute coronary syndrome.
- Helps prevent blood clots in individuals with a history of myocardial infarction.
- Enhances the effectiveness of aspirin when used in combination therapy.
- Improves overall cardiovascular health in high-risk patients.
- May be used in patients undergoing percutaneous coronary intervention (PCI) to prevent thrombotic complications.
- Supports long-term management strategies for patients with established coronary artery disease.
- Can be beneficial for patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI).
Brilinta 90 mg Tablet - Strip of 14
Compositions : Ticagrelor 90mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: AstraZeneca India
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Brilinta 90 mg Tablet is a prescription medication primarily used for the prevention of cardiovascular events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (heart attack). The active ingredient in Brilinta is ticagrelor, which belongs to a class of drugs known as antiplatelet agents. These medications work by inhibiting platelet aggregation, thereby reducing the risk of blood clots that can lead to serious cardiovascular complications. Each Brilinta 90 mg Tablet contains 90 mg of ticagrelor, along with various inactive ingredients that aid in the formulation and absorption of the drug. Brilinta is typically prescribed in conjunction with low-dose aspirin to enhance its effectiveness in preventing thrombotic events. The therapeutic purpose of Brilinta is to lower the incidence of heart attacks, strokes, and other cardiovascular-related issues in at-risk patients. It is essential for patients to follow their healthcare provider's instructions regarding the use of Brilinta 90 mg Tablet to ensure optimal therapeutic outcomes and minimize potential risks associated with its use. As a potent antiplatelet agent, Brilinta plays a crucial role in the management of patients with significant cardiovascular risk factors, making it an important component of modern cardiovascular therapy.
Product Details
- Ticagrelor, the active ingredient in Brilinta 90 mg Tablet, works by reversibly binding to the P2Y12 receptor on platelets.
- This action inhibits adenosine diphosphate (ADP)-induced platelet activation and aggregation.
- By preventing platelets from clumping together, Brilinta reduces the formation of blood clots.
- The rapid onset of action allows for immediate therapeutic effects in acute settings.
- Brilinta's unique mechanism provides a more effective antiplatelet effect compared to some other medications in its class.
- Take Brilinta 90 mg Tablet orally, with or without food, as directed by your healthcare provider.
- The usual recommended dose is one tablet (90 mg) taken twice daily.
- It is important to take Brilinta at the same times each day to maintain consistent blood levels.
- Do not crush or chew the tablet; swallow it whole with water.
- Continue taking Brilinta for as long as prescribed by your healthcare provider, even if you feel well.
- If you miss a dose, take it as soon as you remember unless it is almost time for your next dose; do not double up on doses.
- Consult your healthcare provider for specific dosage adjustments if you have liver or kidney issues.
- Maintain a heart-healthy diet rich in fruits, vegetables, whole grains, and lean proteins.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise each week.
- Avoid smoking and limit alcohol consumption to reduce cardiovascular risks.
- Monitor your blood pressure and cholesterol levels regularly as advised by your healthcare provider.
- Stay hydrated and manage stress through relaxation techniques such as yoga or meditation.
- Keep all scheduled appointments with your healthcare provider for ongoing evaluation and management.
Safety Advice
Side Effects
- Common side effects may include:
- Bleeding or bruising more easily than normal.
- Headache or dizziness.
- Nausea or diarrhea.
- Serious side effects that require immediate medical attention include:
- Signs of severe bleeding such as unusual bruising, blood in urine or stools, or coughing up blood.
- Shortness of breath or chest pain.
- Severe allergic reactions including rash, itching, or swelling.
Precautions and Warnings
- Do not use Brilinta if you have active bleeding disorders or a history of intracranial hemorrhage.
- Inform your healthcare provider about any other medications you are taking to avoid potential interactions.
- Avoid alcohol consumption as it may increase bleeding risk while on this medication.
- Use caution when driving or operating machinery until you know how Brilinta affects you.
- If you are pregnant or breastfeeding, discuss the risks and benefits with your healthcare provider before using this medication.
- Patients with liver or kidney impairment should use Brilinta cautiously and under medical supervision.
FAQs
If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose. Do not take two doses at once.
2. Can I take Brilinta if I am pregnant?
Brilinta should be used during pregnancy only if clearly needed. Consult your healthcare provider for advice.
3. Are there any foods I should avoid while taking Brilinta?
There are no specific food interactions with Brilinta; however, maintaining a healthy diet is recommended.
4. What are the common side effects of Brilinta?
Common side effects include bleeding, bruising, headache, and dizziness. Contact your doctor if these persist.
5. Can I drink alcohol while taking Brilinta?
It's advisable to limit alcohol consumption while taking Brilinta due to potential increased bleeding risk.
6. How should I store Brilinta?
Store Brilinta at room temperature away from moisture and heat. Keep out of reach of children.
7. Who should avoid taking Brilinta?
Patients with active bleeding disorders or a history of intracranial hemorrhage should avoid using Brilinta.
Instructions
No content available for this section.
More Information
| SKU | 172903 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | AstraZeneca India |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Brilinta 90 mg Tablet is a prescription medication primarily used for the prevention of cardiovascular events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (heart attack). The active ingredient in Brilinta is ticagrelor, which belongs to a class of drugs known as antiplatelet agents. These medications work by inhibiting platelet aggregation, thereby reducing the risk of blood clots that can lead to serious cardiovascular complications. Each Brilinta 90 mg Tablet contains 90 mg of ticagrelor, along with various inactive ingredients that aid in the formulation and absorption of the drug. Brilinta is typically prescribed in conjunction with low-dose aspirin to enhance its effectiveness in preventing thrombotic events. The therapeutic purpose of Brilinta is to lower the incidence of heart attacks, strokes, and other cardiovascular-related issues in at-risk patients. It is essential for patients to follow their healthcare provider's instructions regarding the use of Brilinta 90 mg Tablet to ensure optimal therapeutic outcomes and minimize potential risks associated with its use. As a potent antiplatelet agent, Brilinta plays a crucial role in the management of patients with significant cardiovascular risk factors, making it an important component of modern cardiovascular therapy.
- Reduces the risk of heart attacks and strokes in patients with acute coronary syndrome.
- Helps prevent blood clots in individuals with a history of myocardial infarction.
- Enhances the effectiveness of aspirin when used in combination therapy.
- Improves overall cardiovascular health in high-risk patients.
- May be used in patients undergoing percutaneous coronary intervention (PCI) to prevent thrombotic complications.
- Supports long-term management strategies for patients with established coronary artery disease.
- Can be beneficial for patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI).
- Ticagrelor, the active ingredient in Brilinta 90 mg Tablet, works by reversibly binding to the P2Y12 receptor on platelets.
- This action inhibits adenosine diphosphate (ADP)-induced platelet activation and aggregation.
- By preventing platelets from clumping together, Brilinta reduces the formation of blood clots.
- The rapid onset of action allows for immediate therapeutic effects in acute settings.
- Brilinta's unique mechanism provides a more effective antiplatelet effect compared to some other medications in its class.
- Take Brilinta 90 mg Tablet orally, with or without food, as directed by your healthcare provider.
- The usual recommended dose is one tablet (90 mg) taken twice daily.
- It is important to take Brilinta at the same times each day to maintain consistent blood levels.
- Do not crush or chew the tablet; swallow it whole with water.
- Continue taking Brilinta for as long as prescribed by your healthcare provider, even if you feel well.
- If you miss a dose, take it as soon as you remember unless it is almost time for your next dose; do not double up on doses.
- Consult your healthcare provider for specific dosage adjustments if you have liver or kidney issues.
- Maintain a heart-healthy diet rich in fruits, vegetables, whole grains, and lean proteins.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise each week.
- Avoid smoking and limit alcohol consumption to reduce cardiovascular risks.
- Monitor your blood pressure and cholesterol levels regularly as advised by your healthcare provider.
- Stay hydrated and manage stress through relaxation techniques such as yoga or meditation.
- Keep all scheduled appointments with your healthcare provider for ongoing evaluation and management.
Side Effects
- Common side effects may include:
- Bleeding or bruising more easily than normal.
- Headache or dizziness.
- Nausea or diarrhea.
- Serious side effects that require immediate medical attention include:
- Signs of severe bleeding such as unusual bruising, blood in urine or stools, or coughing up blood.
- Shortness of breath or chest pain.
- Severe allergic reactions including rash, itching, or swelling.
Precautions and Warnings
- Do not use Brilinta if you have active bleeding disorders or a history of intracranial hemorrhage.
- Inform your healthcare provider about any other medications you are taking to avoid potential interactions.
- Avoid alcohol consumption as it may increase bleeding risk while on this medication.
- Use caution when driving or operating machinery until you know how Brilinta affects you.
- If you are pregnant or breastfeeding, discuss the risks and benefits with your healthcare provider before using this medication.
- Patients with liver or kidney impairment should use Brilinta cautiously and under medical supervision.
If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose. Do not take two doses at once.
2. Can I take Brilinta if I am pregnant?
Brilinta should be used during pregnancy only if clearly needed. Consult your healthcare provider for advice.
3. Are there any foods I should avoid while taking Brilinta?
There are no specific food interactions with Brilinta; however, maintaining a healthy diet is recommended.
4. What are the common side effects of Brilinta?
Common side effects include bleeding, bruising, headache, and dizziness. Contact your doctor if these persist.
5. Can I drink alcohol while taking Brilinta?
It's advisable to limit alcohol consumption while taking Brilinta due to potential increased bleeding risk.
6. How should I store Brilinta?
Store Brilinta at room temperature away from moisture and heat. Keep out of reach of children.
7. Who should avoid taking Brilinta?
Patients with active bleeding disorders or a history of intracranial hemorrhage should avoid using Brilinta.
No content available for this section.
| SKU | 172903 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | AstraZeneca India |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account